Literature DB >> 25916029

Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran.

M M Soltan Dallal, C F Telefian, M Hajia, E Kalantar, A R Dolatyar Dehkharghani, A Rahimi Forushani, Q Khanbabaei, M Mobarhan, M R Farzami.   

Abstract

INTRODUCTION: B. cepacia complex have emerged as an important opportunistic pathogen in hospitalized and immunocompromised patients. Small hospital outbreaks are frequent and are usually due to a single contaminated environmental source. In this study we were going to investigate the role of B.cepacia complex in those patients suspected to involve with cystic fibrosis and evaluate responsible types in Masih Daneshvary Hospital.
METHODS: One hundred specimens were collected from all admitted patients who were suspected to cystic fibrosis to Masih Daneshvary hospital during one year April 2011 till end of March 2012. All were culture and identified standard procedure. All samples were checked by API system (API20NE) and by specific PCR method for genus Bulkhorderia and Bcc as well. Identified strains were finally tested by PFGE system to identifying specific involving pulse-types. RESULT: . Isolation and identification methods revealed 5 specimens were B.cepasia, The frequency of the cystic fibrosis detected at this study was lower than other similar study previously reported. All these isolates showed similar pattern by PFGE standard protocol that may have spread from a single source and could not be attributed to cross infections from patient to patients. DISCUSSION: Application of PFGE and identification of pulse-type is a potential tool to enhance the investigation of apparent nosocomial outbreaks of B.cepacia. However it needs to be adjusted with environmental findings. Implementation of educational programs and adherence to infection control policies are obviously the main element for complete elimination of an outbreak.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25916029      PMCID: PMC4718333     

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN: 1121-2233


Introduction

The Burkholderia cepacia complex (BCC) is a group of strictly aerobic, gram negative BCC. also known as ''B. cepacia like bacteria''. It currently divided into 17 species that mainly affect people with underlying disease such as cystic fibrosis or granulomatous disease, and show antimicrobial resistant to many of antibiotics [1-3]. The term ''complex'' emerged in the literature at the beginning of the genomic era associated to taxonomy and grouping organisms that belong to different species but exhibited similar patterns according to their morphological, physiological and/or other phenotypic features. DNA–DNA hybridization with 70% and high identity on 16S rRNA gene sequences [4]. Presently, the BCC includes 17 species: B. ambifaria, B. anthina, B. arboris, B. cepacia, B. cenocepacia, B. contaminans, B. diffusa, B. dolosa, B. lata, B. latens, B. metallica, B. multivorans, B. pyrrocinia, B. seminalis, B. stabilis, B. ubonensis, B. vietnamiensis. Among these organisms some authors have detected B. cepacia more frequently than the rest especially in non-CF patients [5]. Bcc is among the pathogens most frequently reported outbreaks and has been described in several healthcare centers around the world [6-13]. These organisms have also emerged as an important cause of morbidity and mortality in hospitalized patients because of high rate of antibiotic resistance [14]. Therefore, fast detection and elimination of the source of such these outbreaks is the great importance in guiding infection control measures and preventing additional cause of infections especially at Cystic Fibrosis centers. The aim of this study was first isolation and identification of Bcc and then to perform molecular typing by pulsed-field gel electrophoresis (PFGE) in order to evaluate the epidemiology of this pathogen in CF patients at Masih Daneshvary Hospital.

Methods

Sampling: One hundred specimens were collected from all admitted patients who were suspected to cystic fibrosis to Masih Daneshvary hospital during one year April 2011 till end of March 2012. Isolation and Identification: Bacterial identification was performed after culturing in BHI broth. One loop broth was then of transferred to blood agar after overnight incubation. Isolates were identified use standard identification tests and with API20NE system as well [15]. After species identification, isolates were stored at -20 oC as suspensions in 10% skim milk solution containing 10% glycerol. PCR Methods: Microbial suspension was prepared for each isolated specimens and extracted use of QIAamp DNA Mini Kit (QIAGEN GmbH, Hilden, Germany). The purity of all the extracted specimens was determined by measuring the optical density at the wavelengths of 260 and 280 nm. Primer pair sequences was order based on the Lynch's report (et al. 2008) [16]. He reported two set of Primer pairs one detecting Bulkhurderia species and the second specific for the BCC (Tab. I).
Tab. I.

Primer sequence used in this study.

TrargetPrimerSequenceSpeciesProduct size
recABCC(F)ATGACCAATCCGACCGATCTCAAAll429(bp)
BCC(R)TCAGTGCTTGCGITNIGGGCAGTT
recABKF(F)GGCNGAAGACGTCTACCGGBCC (Group K)117(bp)
BKF(R)TCGAAGTTGCTGCGCGAC
Primer sequence used in this study. 20 μl mixtures were prepared use of 200 μM of dNTP, 1.5 mM MgCl2,50 pg of each primers, 2U of taq polymerase, 1x PCR buffer and different concentration of each primer. The PCR were performed on Eppendorf thermal cyclers (Mastercycler Gradient) by following program: 96oC for 4 min, then 35 cycles at 96oC, 59oC, and 72oC each for 1 min, at the end 2 min at 59oC. PCR products were analyzed on 2% agarose gel with100 base pair ladder. Genotyping: DNA polymorphisms of all isolates were evaluated by pulsedfield gel electrophoresis (PFGE) with SpeI (Boehringer Mannheim Biochemicals), as described elsewhere. 20 DNA banding patterns were compared by standard DNA marker interpreted by visual inspection. PFGE was briefly performed as follows: bacterial suspension was prepared in a buffer (100 mmol l-1Tris, 100 mmol l-1 EDTA, pH 8.0) and adjusted to absorbance values of 0.8 - 1.0 at a wavelength of 610 nm after which plugs were prepared with SeaKem Gold agarose (Lonza, Rockland, ME, USA) and proteinase K. Bacterial plugs were lysed (50 mmol l-1Tris, 50 mmol l-1 EDTA, 1% sarcosine, and 0.5 mg of proteinase K,pH 8.0) and washed after which digested with forty units of Spe I restriction enzyme (Fermentase). DNA molecular weight size marker was prepared by XbaI digestion of Salmonella enterica serotype Braenderup H9812 plugs. CHEF Mapper XA System (Bio-Rad) was applied for electrophoresis.

Results

Isolation and applied identification testes revealed 5 specimens were Burkholderia cepacia. PCR results also confirmed in these specimens (Tab. II and Fig. 1). The frequency of the cystic fibrosis detected at this study was 5%. It is obviously different at variously reports. Leite and coworkers studied a total of 244 CF patients from HCPA and observed a prevalence rate of BCC of 10.6%. BCC accounted for most BCC isolates in 244 examined specimens [17].
Tab. II.

API results for isolated specimens. All 5 isolated specimens had similar reaction to the standard strains by applied biochemical tests.

PolymixineDNAaseOf MannitolOf MaltoseOf LactoseOrnithineArginineLysineCitrateH2S in KIATSIIndoleMotilityOxidasePigmentColor Gram
R-++++-+w--ALK/ALK-++-Rod g-B. cepacia Standard strain (ATCC25416)
R-++++-+w--ALK/ALK-++-Rod g-Isolated organisms
Fig. 1.

PCR results.

PCR results. API results for isolated specimens. All 5 isolated specimens had similar reaction to the standard strains by applied biochemical tests. PFGE results: PFGE were performed by the standard procedures use of SpeI Restriction enzyme and provide one unique electrophoresis pattern (Fig. 2) meaning similar type involving in those patients suffering cystic fibrosis due to Burkholderia cepacia. Use of XbaI also revealed similar pattern among these 5 isolated organisms. The presence uniform pattern and similar pulsetype in all these identified B.cepacia was concluded just by visual inspection use of standard DNA marker since the system have set up recently and BioNumerics had not been delivered to the molecular lab on running date of experiment. The pattern of each sample was carefully analyzed and experiment repeated once more, although it was necessary to interpret these results by computer software such as gel compare or BioNumerics and drawing related dendrogram.
Fig. 2.

PFGE results.

PFGE results.

Discussion

In 2001, Agodi (et al. 2001) indicated a prevalence of Bcc infection of 9.5% in a study performed in four Italian CF Centers [18]. The frequency rate is obviously different in various reports. The possibility of patientto- patient transfer of B. cepacia in the CF community has always been one of great concerns. Because patients colonized with Bcc may remain colonized for a long periods of time. In some patients, however, Bcc was not isolated for several years and then their first strain reappeared up to 10 years later. In some of these patients, it cannot be excluded that reacquisition from the environment occurred. PFGE has the excessively high discriminatory and reproducible for the epidemiological study of BCC comparison with other typing method [19]. Based on the generated PFGE results by SpeI restriction enzyme all specimens had analogous PFGE pattern with 100% genetic similarity in this study. It is possible that the observed infections may have spread from a single source since having identical PFGE pattern. This suggested hypothesis was supported by the isolation results because no other Burkholderia species was identified during the study over a period from April 2011 till end of March 2012. The unusual species distribution may be attributed to environmental sources besides to cross infections from patient to patients, although having similar pattern. Several epidemiological studies have shown most cases of BCC infection transmitted between CF patients [20]. However, occasionally detected B.cepacia distribution during one year of study may represent the acquisition from the environment as well as other sources cross infections from patient to patients. It is frequently reported B.cepacia has high transmissibility rate and are the responsible microorganism for the mostly nosocomial infections among BCC. B.cepacia infection may result a significant illness, particularly in the cystic fibrosis patients, where patients are at greater risk of nosocomial infection due to their underlying illness. Therefore this finding suggests the importance of adequate patient follow-up in those hospitals that are the referral for CF centers.

Conclusions

Application of PFGE and identification of pulse-type is a potential tool to enhance the investigation of apparent nosocomial outbreaks of B.cepacia. However it needs to be adjusted with environmental findings. Implementation of educational programs and adherence to infection control policies are obviously the main element for complete elimination of an outbreak.
  17 in total

1.  A plasma expander-related Pseudomonas aeruginosa outbreak.

Authors:  Giovanni B Orsi; Paolo Villari; Vanessa Mondillo; Massimo Fabiani; Carolina Marzuillo; Adrio Penni; Mario Venditti
Journal:  Scand J Infect Dis       Date:  2006

2.  An outbreak of Serratia marcescens bloodstream infections associated with misuse of drug vials in a surgical ward.

Authors:  Angelo Pan; Lucia Dolcetti; Catia Barosi; Patrizia Catenazzi; Tomaso Ceruti; Lucio Ferrari; Silvia Magri; Eugenia Quiros Roldan; Laura Soavi; Giuseppe Carnevale
Journal:  Infect Control Hosp Epidemiol       Date:  2006-01-06       Impact factor: 3.254

3.  Outbreak of Burkholderia cepacia bacteremia in immunocompetent children caused by contaminated nebulized sulbutamol in Saudi Arabia.

Authors:  Sameeh S Ghazal; Khaled Al-Mudaimeegh; Elham Mohammed Al Fakihi; Ali Talee Asery
Journal:  Am J Infect Control       Date:  2006-08       Impact factor: 2.918

4.  Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.

Authors:  Rebecca Reik; Theodore Spilker; John J Lipuma
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic.

Authors:  Pavel Drevinek; Sarka Vosahlikova; Ondrej Cinek; Vera Vavrova; Jana Bartosova; Petr Pohunek; Eshwar Mahenthiralingam
Journal:  J Med Microbiol       Date:  2005-07       Impact factor: 2.472

6.  Outbreak of Acinetobacter baumannii bacteremia related to contaminated morphine used for patient-controlled analgesia.

Authors:  Hsin-Chun Lee; Nan-Yao Lee; Chia-Ming Chang; Cheng-Yang Chou; Yi-Hui Wu; Li-Rong Wang; Nai-Ying Ko; Ching-Chuan Liu; Wen-Chien Ko
Journal:  Infect Control Hosp Epidemiol       Date:  2007-08-03       Impact factor: 3.254

7.  Monoclonal outbreak of catheter-related bacteraemia by Ralstonia mannitolilytica on two haemato-oncology wards.

Authors:  Sabine Gröbner; Peter Heeg; Ingo B Autenrieth; Berit Schulte
Journal:  J Infect       Date:  2007-09-19       Impact factor: 6.072

8.  Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse.

Authors:  Jacqueline W Chung; Eleonora Altman; Terry J Beveridge; David P Speert
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.

Authors:  Elke Vanlaere; Adam Baldwin; Dirk Gevers; Deborah Henry; Evie De Brandt; John J LiPuma; Eshwar Mahenthiralingam; David P Speert; Chris Dowson; Peter Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2009-01       Impact factor: 2.747

10.  A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.

Authors:  Rebecca H Sunenshine; Esther T Tan; Dawn M Terashita; Bette J Jensen; Marilyn A Kacica; Emily E Sickbert-Bennett; Judith A Noble-Wang; Michael J Palmieri; Dianna J Bopp; Daniel B Jernigan; Sophia Kazakova; Eddy A Bresnitz; Christina G Tan; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2007-07-24       Impact factor: 9.079

View more
  2 in total

1.  Potential human pathogenic bacteria in five hot springs in Eritrea revealed by next generation sequencing.

Authors:  Amanuel Menghs Ghilamicael; Hamadi Iddi Boga; Sylvester Elikana Anami; Tadesse Mehari; Nancy L M Budambula
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

2.  In silico characteristics for re-emerging possibility of Vibrio cholerae genotypes in Iran.

Authors:  M Hajia; Amir Sohrabi
Journal:  New Microbes New Infect       Date:  2019-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.